Trademark: 97774473
Word
ADENOVERSE
Status
Registered
Status Code
700
Status Date
Tuesday, February 20, 2024
Serial Number
97774473
Registration Number
7309764
Registration Date
Tuesday, February 20, 2024
Mark Type
4000
Filing Date
Tuesday, January 31, 2023
Published for Opposition
Tuesday, December 5, 2023

Trademark Owner History
Precigen, Inc. - Original Registrant

Classifications
44 Medical services, namely, providing medical therapy treatments for patients in the fields of oncology, rare diseases, metabolic disorders, infectious diseases, ophthalmology, and cardiovascular diseases
42 Scientific and technological services and biological research and development relating thereto, namely, research and development utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of immune cells; scientific and technological services and biological research and development, namely, research and development related to treatment of complex diseases; medical research in the field of immunotherapy

Trademark Events
Feb 20, 2024
Notice Of Registration Confirmation Emailed
Feb 20, 2024
Registered-Principal Register
Dec 5, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 5, 2023
Published For Opposition
Nov 15, 2023
Notification Of Notice Of Publication E-Mailed
Oct 30, 2023
Approved For Pub - Principal Register
Oct 30, 2023
Examiner's Amendment Entered
Oct 30, 2023
Notification Of Examiners Amendment E-Mailed
Oct 30, 2023
Examiners Amendment E-Mailed
Oct 30, 2023
Examiners Amendment -Written
Oct 30, 2023
Assigned To Examiner
Feb 17, 2023
New Application Office Supplied Data Entered
Feb 3, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24